T1	SectionAnnotate 34 44	SUBJECTIVE
T2	SectionSkip 2394 2414	CURRENT MEDICATIONS:
T3	SectionSkip 2416 3539	Medications the patient states to be taking prior to today's encounter.   Medication Sig    aspirin 81 mg EC tablet Take 81 mg by mouth Daily.    atorvastatin (LIPITOR) 40 mg tablet TK 1 T PO QD    coenzyme Q10 100 mg capsule Take by mouth Daily.    CREON 36,000-114,000- 180,000 unit capsule Take 3 tabs with meals and 2 tabs with snacks.    metFORMIN (GLUCOPHAGE) 850 mg tablet Take 850 mg by mouth 2 (two) times daily with meals.    methadone (DOLOPHINE) 10 mg tablet Take 10 mg by mouth every 12 (twelve) hours.    metoclopramide HCl (REGLAN) 10 mg tablet     multivitamin with iron-minerals-folic acid (MULTIVITAMIN-IRON-MINERALS-FOLIC ACID) 3,500-18-0.4 unit-mg-mg chewable tablet Take 1 tablet by mouth Daily.    omeprazole (PRILOSEC) 20 mg capsule TK 1 C PO QD    ondansetron (ZOFRAN) 8 mg tablet TK 1 T PO Q 8 H PRN NV    oxyCODONE (ROXICODONE) 5 mg tablet Take 5 mg by mouth every 4 (four) hours as needed for Pain. 1-2 tabs po q 3-4 hours    polyethylene glycol (MIRALAX) 17 gram packet     [DISCONTINUED] CREON 36,000-114,000- 180,000 unit capsule Take 2-3 caps po q snack and August 07 caps po QAC
T4	SectionSkip 3544 3559	ALLERGIES: None
T5	SectionAnnotate 3563 3578	FAMILY HISTORY:
T6	SectionAnnotate 3701 3716	SOCIAL HISTORY:
T7	SectionSkip 4672 6283	LABORATORY RESULTS:  Results for orders placed or performed during the hospital encounter of 09/05/17   Comprehensive Metabolic Panel - UCSF/LabCorp/Quest (BMP, AST, ALT, T.BILI, ALKP, TP, ALB)   Result Value Ref Range    Albumin, Serum / Plasma 3.3 (L) 3.5 - 4.8 g/dL    Alkaline Phosphatase 493 (H) 31 - 95 U/L    Alanine transaminase 387 (H) 11 - 50 U/L    Aspartate transaminase 357 (H) 17 - 42 U/L    Bilirubin, Total 7.4 (H) 0.2 - 1.3 mg/dL    Urea Nitrogen, Serum / Plasma 15 6 - 22 mg/dL    Calcium, total, Serum / Plasma 9.2 8.8 - 10.3 mg/dL    Chloride, Serum / Plasma 94 (L) 97 - 108 mmol/L    Creatinine 0.67 0.44 - 1.00 mg/dL    eGFR if non-African American 90 >60 mL/min    eGFR if African Amer 104 >60 mL/min    Potassium, Serum / Plasma 3.7 3.5 - 5.1 mmol/L    Sodium, Serum / Plasma 133 (L) 135 - 145 mmol/L    Protein, Total, Serum / Plasma 7.5 6.0 - 8.4 g/dL    Carbon Dioxide, Total 27 22 - 32 mmol/L    Anion Gap 12 4 - 14    Glucose, non-fasting 131 70 - 199 mg/dL   Complete Blood Count with 5-part Differential   Result Value Ref Range    WBC Count 15.3 (H) 3.4 - 10 x10E9/L    RBC Count 3.29 (L) 4.0 - 5.2 x10E12/L    Hemoglobin 10.4 (L) 12.0 - 15.5 
 g/dL    Hematocrit 30.8 (L) 36 - 46 %    MCV 94 80 - 100 fL    MCH 31.6 26 - 34 pg    MCHC 33.8 31 - 36 g/dL    Platelet Count 203 140 - 450 x10E9/L    Neutrophil Absolute Count 12.04 (H) 1.8 - 6.8 x10E9/L    Lymphocyte Abs Cnt 1.75 1.0 - 3.4 x10E9/L    Monocyte Abs Count 1.20 (H) 0.2 - 0.8 x10E9/L    Eosinophil Abs Ct 0.01 0.0 - 0.4 x10E9/L    Basophil Abs Count 0.04 0.0 - 0.1 x10E9/L    Imm Gran, Left Shift 0.23 (H) <0.1 x10E9/L
T8	SectionSkip 6288 6338	IMAGING:  No images are attached to the encounter.
T9	PROBLEM 184 260	locally advanced and unresectable adenocarcinoma of the head of the pancreas
T11	Symptom 303 314	weight loss
T12	TREATMENT 428 444	pain medications
T13	TEST 449 457	a workup
T14	Radiology 473 495	CT scan of the abdomen
T15	PROBLEM 522 528	a mass
T16	PROBLEM 599 627	An 11 mm lesion in the liver
T17	Radiology 672 675	EUS
T18	PROBLEM 703 733	a mass in the uncinate process
T19	PROBLEM 738 760	involvement of the SMA
T20	ProcedureName 762 765	FNA
T21	PROBLEM 769 777	the mass
T22	PROBLEM 787 804	an adenocarcinoma
T23	TREATMENT 853 864	gemcitabine
T24	TREATMENT 869 877	Abraxane
T25	PROBLEM 899 923	radiographic progression
T26	TREATMENT 973 997	dose modified FOLFIRINOX
T27	TREATMENT 1039 1049	FOLFIRINOX
T28	PROBLEM 1088 1104	increase fatigue
T29	PROBLEM 1340 1356	increased emesis
T30	PROBLEM 1358 1364	nausea
T31	PROBLEM 1370 1377	burping
T32	PROBLEM 1402 1408	emesis
T33	MedicationName 1469 1475	Zofran
T34	TREATMENT 1495 1505	medication
T35	TREATMENT 1554 1563	many meds
T36	TREATMENT 1597 1603	zofran
T37	TREATMENT 1637 1642	Creon
T38	PROBLEM 1681 1705	Her upper abdominal pain
T39	TREATMENT 1740 1749	Methadone
T40	TREATMENT 1758 1767	Oxycodone
T41	PROBLEM 1833 1851	bilateral LE edema
T42	PROBLEM 1888 1905	decrease swelling
T43	Symptom 1914 1922	leg pain
T44	Symptom 1924 1927	SOB
T45	PROBLEM 1929 1941	chest 
 pain
T46	PROBLEM 1961 1984	continued poor appetite
T47	PROBLEM 2042 2060	dark colored urine
T48	Symptom 2078 2084	fevers
T49	Symptom 2086 2092	chills
T50	Symptom 2094 2102	pruritis
T52	PROBLEM 2203 2223	an oral hypoglycemic
T53	TEST 2225 2241	Her blood sugars
T54	TREATMENT 2274 2289	PRIOR SURGERIES
T55	TREATMENT 2292 2303	IUD removal
T56	ProcedureName 2312 2332	arthroscopic surgery
T57	TREATMENT 2416 2427	Medications
T58	TREATMENT 2490 2500	Medication
T59	TREATMENT 2509 2516	aspirin
T60	TREATMENT 2564 2586	atorvastatin (LIPITOR)
T61	TREATMENT 2617 2629	coenzyme Q10
T62	TREATMENT 2670 2675	CREON
T63	TREATMENT 2764 2786	metFORMIN (GLUCOPHAGE)
T64	TREATMENT 2858 2879	methadone (DOLOPHINE)
T65	TREATMENT 2942 2969	metoclopramide HCl (REGLAN)
T66	TREATMENT 2988 3070	multivitamin with iron-minerals-folic acid (MULTIVITAMIN-IRON-MINERALS-FOLIC ACID)
T67	TREATMENT 3145 3166	omeprazole (PRILOSEC)
T68	TREATMENT 3198 3218	ondansetron (ZOFRAN)
T69	TREATMENT 3251 3280	NV    oxyCODONE (ROXICODONE)
T70	PROBLEM 3347 3351	Pain
T71	TREATMENT 3381 3410	polyethylene glycol (MIRALAX)
T72	TREATMENT 3446 3451	CREON
T73	PROBLEM 3630 3647	pancreatic cancer
T74	PROBLEM 3683 3696	breast cancer
T75	PROBLEM 3933 3950	colorectal cancer
T76	TEST 4042 4048	Vitals
T77	TEST 4050 4052	BP
T78	TEST 4063 4068	Pulse
T79	TEST 4075 4079	Temp
T80	TEST 4085 4086	C
T81	TEST 4106 4110	Resp
T82	TEST 4117 4119	Ht
T83	TEST 4185 4189	SpO2
T84	TEST 4198 4201	BMI
T85	TEST 4253 4257	ECOG
T86	PROBLEM 4284 4299	slight jaundice
T87	PROBLEM 4313 4342	white/yellowish thick coating
T88	PROBLEM 4355 4374	clinical adenopathy
T89	PROBLEM 4389 4400	thyromegaly
T90	PROBLEM 4443 4449	murmur
T91	PROBLEM 4453 4459	gallop
T92	PROBLEM 4474 4483	nontender
T93	PROBLEM 4488 4506	hepatosplenomegaly
T94	PROBLEM 4511 4521	fluid wave
T95	PROBLEM 4526 4532	masses
T96	PROBLEM 4560 4564	rash
T97	PROBLEM 4568 4577	petechiae
T98	PROBLEM 4592 4633	bilateral +1 LE edema from feet to ankles
T99	PROBLEM 4649 4668	gross focal deficit
T100	TEST 4790 4805	Metabolic Panel
T101	TEST 4808 4812	UCSF
T102	TEST 4813 4820	LabCorp
T103	TEST 4828 4831	BMP
T104	TEST 4833 4836	AST
T105	TEST 4838 4841	ALT
T106	TEST 4843 4849	T.BILI
T107	TEST 4851 4855	ALKP
T108	TEST 4857 4859	TP
T109	TEST 4861 4864	ALB
T110	TEST 4875 4880	Value
T111	TEST 4885 4890	Range
T112	TEST 4894 4901	Albumin
T113	TEST 4903 4908	Serum
T114	TEST 4911 4917	Plasma
T115	TEST 4936 4940	g/dL
T116	TEST 4944 4964	Alkaline Phosphatase
T117	TEST 4981 5008	U/L    Alanine transaminase
T118	TEST 5025 5054	U/L    Aspartate transaminase
T119	TEST 5071 5087	U/L    Bilirubin
T120	TEST 5089 5094	Total
T121	TEST 5122 5135	Urea Nitrogen
T122	TEST 5137 5142	Serum
T123	TEST 5145 5151	Plasma
T124	TEST 5171 5178	Calcium
T125	TEST 5187 5192	Serum
T126	TEST 5195 5201	Plasma
T127	TEST 5226 5234	Chloride
T128	TEST 5236 5241	Serum
T129	TEST 5244 5250	Plasma
T130	TEST 5277 5287	Creatinine
T131	TEST 5314 5318	eGFR
T132	TEST 5322 5333	non-African
T133	TEST 5334 5342	American
T134	TEST 5360 5364	eGFR
T135	TEST 5368 5375	African
T136	TEST 5376 5380	Amer
T137	TEST 5399 5408	Potassium
T138	TEST 5410 5415	Serum
T139	TEST 5418 5424	Plasma
T140	TEST 5449 5455	Sodium
T141	TEST 5457 5462	Serum
T142	TEST 5465 5471	Plasma
T143	TEST 5490 5494	mmol
T144	TEST 5500 5507	Protein
T145	TEST 5509 5514	Total
T146	TEST 5516 5521	Serum
T147	TEST 5524 5530	Plasma
T148	TEST 5545 5549	g/dL
T149	TEST 5553 5567	Carbon Dioxide
T150	TEST 5569 5574	Total
T151	TEST 5596 5605	Anion Gap
T152	TEST 5619 5626	Glucose
T153	TEST 5628 5639	non-fasting
T154	TEST 5661 5681	Complete Blood Count
T155	TEST 5716 5721	Value
T156	TEST 5726 5731	Range
T157	TEST 5735 5744	WBC Count
T158	TEST 5751 5752	H
T159	TEST 5774 5783	RBC Count
T160	TEST 5790 5791	L
T161	TEST 5815 5825	Hemoglobin
T162	TEST 5849 5853	g/dL
T163	TEST 5857 5867	Hematocrit
T164	TEST 5874 5876	L)
T165	TEST 5890 5893	MCV
T166	TEST 5912 5915	MCH
T167	TEST 5929 5931	pg
T168	TEST 5935 5939	MCHC
T169	TEST 5953 5957	g/dL
T170	TEST 5961 5975	Platelet Count
T171	TEST 5990 5995	x10E9
T172	TEST 6001 6011	Neutrophil
T173	TEST 6012 6026	Absolute Count
T174	TEST 6034 6035	H
T175	TEST 6047 6052	x10E9
T176	TEST 6058 6072	Lymphocyte Abs
T177	TEST 6073 6076	Cnt
T178	TEST 6092 6097	x10E9
T179	TEST 6103 6115	Monocyte Abs
T180	TEST 6116 6121	Count
T181	TEST 6128 6129	H
T182	TEST 6141 6146	x10E9
T183	TEST 6152 6166	Eosinophil Abs
T184	TEST 6167 6169	Ct
T185	TEST 6185 6190	x10E9
T186	TEST 6196 6208	Basophil Abs
T187	TEST 6209 6214	Count
T188	TEST 6245 6249	Gran
T189	TEST 6251 6261	Left Shift
T190	TEST 6276 6295	x10E9/L     IMAGING
T191	PROBLEM 6365 6405	Localized adenocarcinoma of the pancreas
T192	TREATMENT 6410 6417	therapy
T193	PROBLEM 6423 6448	uncertain disease control
T194	TREATMENT 6481 6491	FOLFIRINOX
T195	TEST 6523 6527	labs
T196	PROBLEM 6546 6565	disease progression
T197	ClinicalCondition 6567 6586	biliary obstruction
T198	ClinicalCondition 6591 6612	ascending cholangitis
T199	TEST 6614 6620	T bili
T200	TEST 6626 6634	Alk Phos
T201	TEST 6640 6643	AST
T202	TEST 6649 6652	ALT
T203	TEST 6671 6689	her most recent CT
T204	TEST 6725 6735	outside CT
T205	ClinicalCondition 6776 6794	hyperbilirubinemia
T206	TEST 6870 6884	urgent imaging
T207	PROBLEM 6897 6922	biliary ductal dilatation
T208	PROBLEM 6930 6962	disease progression in the liver
T209	TREATMENT 6964 6978	ED precautions
T210	ClinicalCondition 7050 7061	cholangitis
T211	PROBLEM 7123 7129	fevers
T212	Symptom 7130 7136	chills
T213	PROBLEM 7172 7184	daily emesis
T214	PROBLEM 7207 7238	partial small bowel obstruction
T215	PROBLEM 7324 7342	Bilateral LE edema
T216	TEST 7365 7377	bilateral US
T217	PROBLEM 7391 7394	DVT
T218	PROBLEM 7403 7420	Multiple symptoms
T219	TREATMENT 7462 7472	management
T220	PROBLEM 7476 7484	her pain
T221	Symptom 7486 7493	fatigue
T222	Symptom 7499 7507	anorexia
T223	TREATMENT 7679 7697	the treatment plan
T224	PROBLEM 7717 7725	symptoms
T225	TEST 7760 7775	Today's CT scan
T226	PROBLEM 7866 7915	ill-defined pancreatic head/uncinate process mass
T227	PROBLEM 7930 7972	obstruction of the biliary system distally
T228	PROBLEM 7978 8042	proximal intrahepatic and extrahepatic biliary ductal dilatation
T229	PROBLEM 8044 8082	Increased pancreatic ductal dilatation
T230	PROBLEM 8091 8126	Increased distention of the stomach
T231	PROBLEM 8132 8174	narrowing of the third portion of duodenum
T232	PROBLEM 8190 8201	mass effect
T233	PROBLEM 8207 8231	adjacent pancreatic mass
T234	PROBLEM 8262 8281	partial obstruction
T235	TEST 8315 8322	an ERCP
T236	TREATMENT 8390 8404	ED precautions
T237	TEST 8424 8442	Lower extremity US
T238	PROBLEM 8460 8468	any DVTs
T239	ClinicalCondition 218 260	adenocarcinoma of the head of the pancreas
A1	ChronicVal T239 non-chronic
A2	ContinuityVal T239 unclear
T240	Histology 218 232	adenocarcinoma
A3	IsPresentOnFirstCancerDiagnosis T11 yes
A4	IsCausedByDiagnosedCancer T11 yes
A5	ChronicVal T11 non-chronic
A6	ContinuityVal T11 new
T10	Symptom 284 298	abdominal pain
A7	IsPresentOnFirstCancerDiagnosis T10 yes
A8	IsCausedByDiagnosedCancer T10 yes
A9	ChronicVal T10 non-chronic
A10	ContinuityVal T10 new
T241	Datetime 327 335;349 353	November 2016
T242	Datetime 340 353	December 2016
R1	HappensAtOnDuring Arg1:T10 Arg2:T241	
R2	HappensAtOnDuring Arg1:T11 Arg2:T241	
T243	Datetime 401 414	February 2017
T244	TreatmentType 428 444	pain medications
A11	TreatmentContinuityVal T244 unclear
A12	TreatmentTypeVal T244 others
A13	TreatmentIntentVal T244 others
R3	TreatmentAdministeredForProblem Treatment:T244 Prob:T10	
R4	BeginsOnOrAt Arg1:T243 Arg2:T244	
A14	IntentVal T14 diagnosis
A15	IntentVal T17 diagnosis
T245	Datetime 504 514	03/08/2017
T246	RadPathResult 524 528	mass
A16	RadPathResultVal T246 InitialCancerDiagnosis
R5	ResultOfTest Desc:T246 Test:T14	
T247	Size 539 557	3.6 x 4.3 x 4.3 cm
A17	EpisodeDescription T247 FirstOccurrence
R6	SizeOf Arg1:T247 Arg2:T246	
R7	HappensAtOnDuring Arg1:T245 Arg2:T14	
T248	Size 602 607	11 mm
T249	RadPathResult 608 614	lesion
A18	NegationModalityVal T249 uncertain_in_present
A19	RadPathResultVal T249 InitialCancerDiagnosis
R8	SizeOf Arg1:T248 Arg2:T249	
R9	ResultOfTest Desc:T249 Test:T14	
T250	LocalInvasion 559 579	Vascular involvement
A20	NegationModalityVal T250 negated
A21	EpisodeDescription T250 FirstOccurrence
R10	TestOrProcedureReveals Test:T14 Desc:T250	
T251	Datetime 684 695	February 21
T252	RadPathResult 705 709	mass
A22	RadPathResultVal T252 InitialCancerDiagnosis
T253	RadPathResult 773 777	mass
A23	RadPathResultVal T253 InitialCancerDiagnosis
T254	Site 717 733	uncinate process
T255	Site 757 760	SMA
T256	LocalInvasion 738 749	involvement
A24	EpisodeDescription T256 FirstOccurrence
R11	SiteOf Arg1:T255 Arg2:T256	
R12	SiteOf Arg1:T254 Arg2:T252	
R13	ResultOfTest Desc:T252 Test:T17	
R14	TestOrProcedureReveals Test:T17 Desc:T256	
A25	IntentVal T20 diagnosis
A26	TreatmentTypeVal T20 others
A27	TreatmentCategory T20 Others
A28	IsTumorRemaining T20 yes
R15	ResultOfTest Desc:T253 Test:T17	
T257	Histology 790 804	adenocarcinoma
A29	EpisodeDescription T257 FirstOccurrence
R16	TestOrProcedureReveals Test:T20 Desc:T257	
T258	MedicationRegimen 853 877	gemcitabine and Abraxane
A30	TreatmentContinuityVal T258 discontinued_early
A31	TreatmentTypeVal T258 maintenance
A32	TreatmentIntentVal T258 palliative
T259	DiseaseState 899 923	radiographic progression
A33	DiseaseStateVal T259 progression-others
R17	TreatmentDiscontinuedBecauseOf Therapy:T258 Reason:T259	
T260	Datetime 927 938	06/14/2017.
R18	HappensAtOnDuring Arg1:T260 Arg2:T259	
T261	MedicationRegimen 973 997	dose modified FOLFIRINOX
A34	TreatmentContinuityVal T261 started
A35	TreatmentTypeVal T261 maintenance
A36	TreatmentIntentVal T261 palliative
T262	Datetime 1007 1015	07/31/17
T263	Cycles 999 1003	C1D1
R19	TreatmentDesc Therapy:T263 Desc:T261	
R20	BeginsOnOrAt Arg1:T262 Arg2:T261	
T264	Datetime 1022 1032	08/15/2017
T265	MedicationRegimen 1039 1049	FOLFIRINOX
A37	TreatmentContinuityVal T265 continuing
A38	TreatmentTypeVal T265 maintenance
A39	TreatmentIntentVal T265 palliative
T266	Cycles 1034 1038	C2D1
R21	TreatmentDesc Therapy:T266 Desc:T265	
T267	Symptom 1097 1104	fatigue
A40	IsPresentOnFirstCancerDiagnosis T267 no
A41	IsCausedByDiagnosedCancer T267 no
A42	ChronicVal T267 non-chronic
A43	ContinuityVal T267 worsening
T268	Symptom 1350 1356	emesis
A44	IsPresentOnFirstCancerDiagnosis T268 no
A45	IsCausedByDiagnosedCancer T268 no
A46	ChronicVal T268 non-chronic
A47	ContinuityVal T268 worsening
T269	Symptom 1358 1364	nausea
A48	IsPresentOnFirstCancerDiagnosis T269 no
A49	IsCausedByDiagnosedCancer T269 no
A50	ChronicVal T269 non-chronic
A51	ContinuityVal T269 worsening
T270	Symptom 1370 1377	burping
A52	IsPresentOnFirstCancerDiagnosis T270 no
A53	IsCausedByDiagnosedCancer T270 no
A54	ChronicVal T270 non-chronic
A55	ContinuityVal T270 worsening
R22	ConditionOrTreatmentCausesProblem Treatment:T265 Prob:T267	
R23	ConditionOrTreatmentCausesProblem Treatment:T265 Prob:T268	
R24	ConditionOrTreatmentCausesProblem Treatment:T265 Prob:T269	
T271	Symptom 1402 1408	emesis
A56	IsPresentOnFirstCancerDiagnosis T271 no
A57	IsCausedByDiagnosedCancer T271 no
A58	ChronicVal T271 non-chronic
A59	ContinuityVal T271 worsening
T272	Frequency 1383 1398	2 or 3 episodes
R25	Temporal Arg1:T272 Arg2:T271	
A60	TreatmentContinuityVal T33 continuing
A61	TreatmentTypeVal T33 others
A62	TreatmentIntentVal T33 others
A63	TreatmentCategory T33 Supportive
R26	TreatmentAdministeredForProblem Treatment:T33 Prob:T271	
T273	MedicationName 1597 1603	zofran
A64	TreatmentContinuityVal T273 continuing
A65	TreatmentTypeVal T273 others
A66	TreatmentIntentVal T273 others
A67	TreatmentCategory T273 Supportive
R27	TreatmentAdministeredForProblem Treatment:T273 Prob:T271	
T274	MedicationName 1637 1642	Creon
A68	TreatmentContinuityVal T274 continuing
A69	TreatmentTypeVal T274 others
A70	TreatmentIntentVal T274 others
A71	TreatmentCategory T274 Supportive
T275	TreatmentDosage 1643 1649	3 tabs
T276	TreatmentDosage 1661 1667	2 tabs
R28	TreatmentDesc Therapy:T275 Desc:T274	
R29	TreatmentDesc Therapy:T276 Desc:T274	
T277	MedicationName 1740 1749	Methadone
A72	TreatmentContinuityVal T277 continuing
A73	TreatmentTypeVal T277 others
A74	TreatmentIntentVal T277 others
A75	TreatmentCategory T277 Supportive
T278	MedicationName 1758 1767	Oxycodone
A76	TreatmentContinuityVal T278 continuing
A77	TreatmentTypeVal T278 others
A78	TreatmentIntentVal T278 others
A79	TreatmentCategory T278 Supportive
T279	Symptom 1691 1705	abdominal pain
A80	IsPresentOnFirstCancerDiagnosis T279 yes
A81	IsCausedByDiagnosedCancer T279 yes
A82	ChronicVal T279 non-chronic
A83	ContinuityVal T279 stable
T280	Site 1685 1690	upper
R30	SiteOf Arg1:T280 Arg2:T279	
R31	TreatmentAdministeredForProblem Treatment:T277 Prob:T279	
R32	TreatmentAdministeredForProblem Treatment:T278 Prob:T279	
T281	Frequency 1750 1753	BID
T282	Frequency 1768 1771	PRN
T283	Frequency 1781 1792	twice a day
R33	Temporal Arg1:T281 Arg2:T277	
R34	Temporal Arg1:T282 Arg2:T278	
R35	Temporal Arg1:T283 Arg2:T278	
T284	Duration 1817 1821	1 wk
T285	Symptom 1843 1851	LE edema
A84	IsPresentOnFirstCancerDiagnosis T285 unclear
A85	IsCausedByDiagnosedCancer T285 unclear
A86	ChronicVal T285 non-chronic
A87	ContinuityVal T285 new
R36	Temporal Arg1:T284 Arg2:T285	
T286	Site 1833 1842	bilateral
R37	SiteOf Arg1:T286 Arg2:T285	
A88	NegationModalityVal T43 negated
A89	NegationModalityVal T44 negated
T287	Symptom 1929 1934;1937 1941	chest pain
A90	NegationModalityVal T287 negated
T288	Symptom 1971 1984	poor appetite
A91	NegationModalityVal T288 affirmed
A92	IsPresentOnFirstCancerDiagnosis T288 unclear
A93	IsCausedByDiagnosedCancer T288 unclear
A94	ChronicVal T288 non-chronic
A95	ContinuityVal T288 stable
T289	Symptom 1994 2012	gained some weight
A96	NegationModalityVal T289 negated
T290	Symptom 2042 2060	dark colored urine
A97	NegationModalityVal T290 affirmed
A98	IsPresentOnFirstCancerDiagnosis T290 no
A99	IsCausedByDiagnosedCancer T290 yes
A100	ChronicVal T290 non-chronic
A101	ContinuityVal T290 new
T291	Duration 2063 2069	3 days
R38	Temporal Arg1:T291 Arg2:T290	
A102	NegationModalityVal T48 negated
A103	NegationModalityVal T49 negated
A104	NegationModalityVal T50 negated
T51	ClinicalCondition 2175 2183	diabetes
A105	ChronicVal T51 chronic
A106	ContinuityVal T51 improving
T292	Datetime 2187 2191	2007
R39	BeginsOnOrAt Arg1:T292 Arg2:T51	
T293	MedicationName 2206 2223	oral hypoglycemic
A107	NegationModalityVal T293 affirmed
A108	TreatmentContinuityVal T293 finished
A109	TreatmentTypeVal T293 others
A110	TreatmentIntentVal T293 others
A111	TreatmentCategory T293 Others
R40	TreatmentAdministeredForProblem Treatment:T293 Prob:T51	
T294	ProcedureName 2292 2303	IUD removal
A112	IntentVal T294 others
A113	TreatmentTypeVal T294 others
A114	TreatmentCategory T294 Others
A115	IntentVal T56 others
A116	TreatmentTypeVal T56 others
A117	TreatmentCategory T56 Others
T295	Site 2338 2342	knee
T296	Duration 1119 1126	3 weeks
R41	Temporal Arg1:T296 Arg2:T267	
T297	Laterality 2333 2337	left
R42	LateralityOfSite Arg1:T297 Arg2:T295	
R43	SiteOf Arg1:T295 Arg2:T56	
T298	Duration 2350 2361	8 years ago
R44	HappensBefore Arg1:T298 Arg2:T56	
T299	Tobacco 3723 3730	tobacco
A118	IsStoppedOrContinuing T299 stopped
T301	Alcohol 3787 3800	alcohol abuse
A119	NegationModalityVal T301 negated
T302	Employment 3809 3816	retired
A120	NegationModalityVal T302 affirmed
A121	IsStoppedOrContinuing T302 stopped
T303	Employment 3833 3851	worked for   *****	
A122	IsStoppedOrContinuing T303 stopped
T304	MaritalStatus 3903 3908	widow
A123	IsStoppedOrContinuing T304 stopped
T305	ClinicalCondition 3933 3950	colorectal cancer
A124	ExperiencerVal T305 others
T306	SectionSkip 4037 4668	PE:  Vitals: BP 132/85  | Pulse 76  | Temp 36.5 C (97.7 F) (Oral)  | Resp 18  | Ht 163.1 cm (5' 4.21") Comment: April 2017 | Wt 45.4 kg (100 lb)  | SpO2 100%  | BMI 17.05 kg/m    In general, she appears comfortable. ECOG 1  Head: Conjunctiva with slight jaundice. Tongue with white/yellowish thick coating.   Nodes no clinical adenopathy  Neck without thyromegaly  Lungs clear to A and P  Heart RR without murmur or gallop  Abd soft and nontender. No hepatosplenomegaly. No fluid wave. No masses  GU not done  Skin without rash or petechiae  Extremities: bilateral +1 LE edema from feet to ankles  Neuro without gross focal deficit
A125	SectionSkipType T306 physical_exam
T307	SectionSkip 4672 5846;5849 6283	LABORATORY RESULTS:  Results for orders placed or performed during the hospital encounter of 09/05/17   Comprehensive Metabolic Panel - UCSF/LabCorp/Quest (BMP, AST, ALT, T.BILI, ALKP, TP, ALB)   Result Value Ref Range    Albumin, Serum / Plasma 3.3 (L) 3.5 - 4.8 g/dL    Alkaline Phosphatase 493 (H) 31 - 95 U/L    Alanine transaminase 387 (H) 11 - 50 U/L    Aspartate transaminase 357 (H) 17 - 42 U/L    Bilirubin, Total 7.4 (H) 0.2 - 1.3 mg/dL    Urea Nitrogen, Serum / Plasma 15 6 - 22 mg/dL    Calcium, total, Serum / Plasma 9.2 8.8 - 10.3 mg/dL    Chloride, Serum / Plasma 94 (L) 97 - 108 mmol/L    Creatinine 0.67 0.44 - 1.00 mg/dL    eGFR if non-African American 90 >60 mL/min    eGFR if African Amer 104 >60 mL/min    Potassium, Serum / Plasma 3.7 3.5 - 5.1 mmol/L    Sodium, Serum / Plasma 133 (L) 135 - 145 mmol/L    Protein, Total, Serum / Plasma 7.5 6.0 - 8.4 g/dL    Carbon Dioxide, Total 27 22 - 32 mmol/L    Anion Gap 12 4 - 14    Glucose, non-fasting 131 70 - 199 mg/dL   Complete Blood Count with 5-part Differential   Result Value Ref Range    WBC Count 15.3 (H) 3.4 - 10 x10E9/L    RBC Count 3.29 (L) 4.0 - 5.2 x10E12/L    Hemoglobin 10.4 (L) 12.0 - 15.5 g/dL    Hematocrit 30.8 (L) 36 - 46 %    MCV 94 80 - 100 fL    MCH 31.6 26 - 34 pg    MCHC 33.8 31 - 36 g/dL    Platelet Count 203 140 - 450 x10E9/L    Neutrophil Absolute Count 12.04 (H) 1.8 - 6.8 x10E9/L    Lymphocyte Abs Cnt 1.75 1.0 - 3.4 x10E9/L    Monocyte Abs Count 1.20 (H) 0.2 - 0.8 x10E9/L    Eosinophil Abs Ct 0.01 0.0 - 0.4 x10E9/L    Basophil Abs Count 0.04 0.0 - 0.1 x10E9/L    Imm Gran, Left Shift 0.23 (H) <0.1 x10E9/L
A126	SectionSkipType T307 laboratory
T308	ClinicalCondition 6375 6405	adenocarcinoma of the pancreas
A127	ChronicVal T308 non-chronic
A128	ContinuityVal T308 unclear
T309	Histology 6375 6389	adenocarcinoma
A129	EpisodeDescription T309 FirstOccurrence
T310	TreatmentType 6410 6417	therapy
A130	TreatmentContinuityVal T310 continuing
A131	TreatmentIntentVal T310 palliative
T311	DiseaseState 6423 6448	uncertain disease control
A132	DiseaseStateVal T311 others
T312	MedicationRegimen 6481 6491	FOLFIRINOX
A133	TreatmentContinuityVal T312 continuing
A134	TreatmentTypeVal T312 maintenance
A135	TreatmentIntentVal T312 palliative
R46	TreatmentAdministeredForProblem Treatment:T312 Prob:T308	
T313	Cycles 6469 6470	2
R47	TreatmentDesc Therapy:T313 Desc:T312	
T314	Cycles 6511 6512	3
R48	TreatmentDesc Therapy:T314 Desc:T312	
T315	LabTestResult 6523 6527	labs
A136	LabTestResultVal T315 abnormal
T316	DiseaseState 6546 6565	disease progression
A137	NegationModalityVal T316 uncertain_in_present
A138	DiseaseStateVal T316 progression-others
A139	ChronicVal T197 non-chronic
A140	ContinuityVal T197 new
A141	ChronicVal T198 non-chronic
A142	ContinuityVal T198 new
A143	NegationModalityVal T197 uncertain_in_present
A144	NegationModalityVal T198 uncertain_in_present
T317	Radiology 6687 6689	CT
A145	IntentVal T317 unclear
T318	Radiology 6733 6735	CT
A146	IntentVal T318 unclear
T319	Datetime 6741 6749	06/14/17
R49	HappensAtOnDuring Arg1:T319 Arg2:T318	
R50	HappensAtOnDuring Arg1:T319 Arg2:T317	
A147	ChronicVal T205 non-chronic
A148	ContinuityVal T205 new
R51	ExclusionCriteriaFor Arg1:T205 Arg2:T312	
T320	Radiology 6877 6884	imaging
A149	NegationModalityVal T320 planned_in_future
A150	IntentVal T320 diagnosis
T321	ClinicalCondition 6897 6922	biliary ductal dilatation
A151	NegationModalityVal T321 uncertain_in_present
R52	TestOrProcedureConductedForProblem Test:T320 Prob:T321	
T322	Metastasis 6930 6949	disease progression
A152	NegationModalityVal T322 uncertain_in_present
A153	EpisodeDescription T322 Progression
T323	Site 6957 6962	liver
R53	SiteOf Arg1:T323 Arg2:T322	
R54	TestOrProcedureConductedForProblem Test:T320 Prob:T322	
A154	NegationModalityVal T210 uncertain_in_present
A155	ChronicVal T210 non-chronic
A156	ContinuityVal T210 new
T324	Symptom 7123 7129	fevers
A157	NegationModalityVal T324 hypothetical_in_future
A158	IsPresentOnFirstCancerDiagnosis T324 unclear
A159	IsCausedByDiagnosedCancer T324 unclear
A160	ContinuityVal T324 new
A161	NegationModalityVal T212 hypothetical_in_future
A162	IsPresentOnFirstCancerDiagnosis T212 unclear
A163	IsCausedByDiagnosedCancer T212 unclear
A164	ContinuityVal T212 new
T325	Symptom 7178 7184	emesis
A165	NegationModalityVal T325 affirmed
A166	IsPresentOnFirstCancerDiagnosis T325 no
A167	IsCausedByDiagnosedCancer T325 unclear
A168	ContinuityVal T325 unclear
T326	Frequency 7172 7177	daily
R55	Temporal Arg1:T326 Arg2:T325	
T327	ClinicalCondition 7207 7238	partial small bowel obstruction
A169	NegationModalityVal T327 uncertain_in_present
A170	ChronicVal T327 non-chronic
R56	ConditionOrTreatmentCausesProblem Treatment:T327 Prob:T325	
T328	Symptom 7337 7342	edema
A171	IsPresentOnFirstCancerDiagnosis T328 no
A172	ChronicVal T328 non-chronic
A173	ContinuityVal T328 new
T329	Site 7334 7336	LE
T330	Laterality 7324 7333	Bilateral
R57	LateralityOfSite Arg1:T330 Arg2:T329	
R58	SiteOf Arg1:T329 Arg2:T328	
T331	Radiology 7375 7377	US
A174	IntentVal T331 others
R59	TestOrProcedureConductedForProblem Test:T331 Prob:T328	
T332	Site 7365 7374	bilateral
R60	SiteOf Arg1:T332 Arg2:T331	
T333	ClinicalCondition 7391 7394	DVT
A175	NegationModalityVal T333 uncertain_in_present
R61	TestOrProcedureConductedForProblem Test:T331 Prob:T333	
T334	Symptom 7480 7484	pain
A176	IsPresentOnFirstCancerDiagnosis T334 yes
A177	IsCausedByDiagnosedCancer T334 yes
A178	ChronicVal T334 non-chronic
A179	ContinuityVal T334 unclear
A180	IsPresentOnFirstCancerDiagnosis T221 yes
A181	IsCausedByDiagnosedCancer T221 yes
A182	ChronicVal T221 non-chronic
A183	ContinuityVal T221 unclear
A184	IsPresentOnFirstCancerDiagnosis T222 yes
A185	IsCausedByDiagnosedCancer T222 yes
A186	ChronicVal T222 non-chronic
A187	ContinuityVal T222 unclear
T335	Radiology 7768 7770	CT
A188	NegationModalityVal T335 affirmed
A189	IntentVal T335 diagnosis
T336	Datetime 7825 7835	06/14/2017
T337	Datetime 7760 7765	Today
R62	HappensAtOnDuring Arg1:T337 Arg2:T335	
T338	RadPathResult 7866 7877;7911 7915	ill-defined mass
A190	RadPathResultVal T338 Progression
T339	Site 7878 7910	pancreatic head/uncinate process
T340	DiseaseState 7837 7862	interval increase in size
A191	DiseaseStateVal T340 progression-others
R63	TestOrProcedureReveals Test:T335 Desc:T340	
R64	ResultOfTest Desc:T338 Test:T335	
T342	Site 7964 7972	distally
T344	Site 7978 8016	proximal intrahepatic and extrahepatic
T346	Site 8119 8126	stomach
T347	Site 8149 8174	third portion of duodenum
T348	Site 8207 8226	adjacent pancreatic
T343	RadPathResult 8017 8042	biliary ductal dilatation
A194	RadPathResultVal T343 Others
R67	SiteOf Arg1:T344 Arg2:T343	
R68	ResultOfTest Desc:T343 Test:T335	
T341	RadPathResult 7930 7963	obstruction of the biliary system
A192	RadPathResultVal T341 Others
R65	SiteOf Arg1:T342 Arg2:T341	
R66	ResultOfTest Desc:T341 Test:T335	
T345	RadPathResult 8044 8082	Increased pancreatic ductal dilatation
A193	RadPathResultVal T345 Others
T349	RadPathResult 8091 8111	Increased distention
A195	RadPathResultVal T349 Others
T350	RadPathResult 8132 8141	narrowing
A196	RadPathResultVal T350 Others
T351	RadPathResult 8190 8201	mass effect
A197	RadPathResultVal T351 Others
T352	RadPathResult 8227 8231	mass
A198	RadPathResultVal T352 Others
T353	ClinicalCondition 8262 8281	partial obstruction
A199	ChronicVal T353 non-chronic
A200	ContinuityVal T353 new
R69	SiteOf Arg1:T348 Arg2:T352	
R70	SiteOf Arg1:T347 Arg2:T351	
R71	SiteOf Arg1:T347 Arg2:T350	
R72	SiteOf Arg1:T346 Arg2:T349	
R73	TestOrProcedureReveals Test:T335 Desc:T353	
A201	NegationModalityVal T353 uncertain_in_present
R74	ResultOfTest Desc:T349 Test:T335	
R75	ResultOfTest Desc:T350 Test:T335	
R76	ResultOfTest Desc:T351 Test:T335	
R77	ResultOfTest Desc:T352 Test:T335	
T354	ProcedureName 8318 8322	ERCP
A202	NegationModalityVal T354 hypothetical_in_future
A203	IntentVal T354 others
A204	TreatmentTypeVal T354 others
A205	TreatmentCategory T354 Others
T355	Radiology 8440 8442	US
A206	IntentVal T355 others
T356	Site 8424 8439	Lower extremity
R78	SiteOf Arg1:T356 Arg2:T355	
T357	ClinicalCondition 8464 8468	DVTs
A207	NegationModalityVal T357 negated
R79	TestOrProcedureReveals Test:T355 Desc:T357	
T358	Age 70 72	69
T359	PatientCharacteristics 82 98	African-American
R80	TestOrProcedureReveals Test:T14 Desc:T247	
R81	TestOrProcedureReveals Test:T14 Desc:T248	
R82	HappensAtOnDuring Arg1:T17 Arg2:T251	
T360	LivingCondition 1210 1268	moved in with her daughter and is living with her in *****
A208	IsStoppedOrContinuing T360 continuing
T361	PerformanceStatus 1276 1313	able to get up and go for short walks
A209	IsStoppedOrContinuing T361 continuing
A210	PerformanceStatusType T361 Other
T362	Datetime 2305 2309	1977
R83	HappensAtOnDuring Arg1:T294 Arg2:T362	
T300	Age 3751 3753	17
T363	Age 3754 3756	34
R45	BeginsOnOrAt Arg1:T299 Arg2:T300	
R84	EndsOnOrAt Arg1:T299 Arg2:T363	
T364	PatientCharacteristics 3960 3970	1 daughter
R86	HappensAfter Arg1:T335 Arg2:T336	
R87	SiteOf Arg1:T339 Arg2:T338	
R88	SiteOf Arg1:T339 Arg2:T340	
T365	LocalInvasion 205 217	unresectable
R85	TumorDesc TumorDetails:T365 Desc:T239	
R89	HappensAtOnDuring Arg1:T251 Arg2:T20	
R90	HappensAtOnDuring Arg1:T264 Arg2:T265	
R91	HappensOverlapping Arg1:T264 Arg2:T267	
T366	ClinicalCondition 3630 3647	pancreatic cancer
A211	ExperiencerVal T366 family
T367	ClinicalCondition 3683 3696	breast cancer
A212	ExperiencerVal T367 family
T368	Age 3659 3661	57
R92	HappensAtOnDuring Arg1:T368 Arg2:T366	
R93	NotUndergoneBecauseOf Arg1:T312 Reason:T205	
R94	NotUndergoneBecauseOf Arg1:T312 Reason:T197	
R95	NotUndergoneBecauseOf Arg1:T312 Reason:T198	
R96	HappensAtOnDuring Arg1:T319 Arg2:T205	
T369	ap_end 8464 8469	DVTs.
T370	ap_start 6342 6352	ASSESSMENT
T371	hpi_end 2094 2103	pruritis.
T372	hpi_start 34 44	SUBJECTIVE
R97	EndsOnOrAt Arg1:T258 Arg2:T260	
R98	HappensAtOnDuring Arg1:T263 Arg2:T262	
